Astex Pharmaceuticals, Inc. – Strategic SWOT Analysis Review

Date: 2016-01

“Astex Pharmaceuticals, Inc. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – GlobalData’s summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.


Astex Pharmaceuticals, Inc. (Astex Pharmaceuticals), formerly SuperGen, Inc., is a novel drug discovery and development company, committed to the fight against cancer and central nervous system diseases. It discovers and develops small molecule therapeutics. The company’s lead product Dacogen (indicated for the treatment of myelodysplastic syndromes) is marketed by Otsuka in the USA and by Janssen in the rest of the world. It has established a strong pipeline of small molecule, molecularly targeted drugs for treating hematologic malignancies, solid tumors, melanoma and myelodysplastic syndromes. Astex Pharmaceuticals is also advancing several of its compounds in clinical trials in collaboration with Novartis, AstraZeneca, GSK and Janssen. Astex Pharmaceuticals is a subsidiary of Otsuka Pharmaceutical Co., Ltd. and is headquartered in Pleasanton, California, the US.

Astex Pharmaceuticals, Inc. Key Recent Developments

Jul 29, 2015: Otsuka Pharmaceutical’s Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of Cambridge
Oct 14, 2013: Astex Pharmaceuticals to Present at AACR-NCI-EORTC
Sep 03, 2013: Astex Pharmaceuticals to Present at Investor Conferences in September
Aug 01, 2013: Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results
Jul 29, 2013: Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample